To avoid the tumor suppressive effects of cGAS/STING mediated signaling transduction, cancer cells adapt to lower the baseline activity of cGAS-STING signal axis, and thus escape the cGAS mediated innate immune surveillance. The gene discussed is STING1; the disease is cancer.